0001415889-24-016969.txt : 20240614 0001415889-24-016969.hdr.sgml : 20240614 20240614170019 ACCESSION NUMBER: 0001415889-24-016969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240612 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenwood Luba CENTRAL INDEX KEY: 0001853815 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39692 FILM NUMBER: 241045747 MAIL ADDRESS: STREET 1: C/O BROOKLYN IMMUNOTHERAPEUTICS LLC STREET 2: 140 58TH STREET, BUILDING A, SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IN8BIO, INC. CENTRAL INDEX KEY: 0001740279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: Incysus Therapeutics, Inc. DATE OF NAME CHANGE: 20180510 4 1 form4-06142024_050614.xml X0508 4 2024-06-12 0001740279 IN8BIO, INC. INAB 0001853815 Greenwood Luba C/O IN8BIO, INC. 350 5TH AVE. SUITE 5330 NEW YORK NY 10118 true false false false 0 Stock Option (right to buy) 1.47 2024-06-12 4 A 0 33650 0 A 2034-06-12 Common Stock 33650 33650 D One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 12, 2024; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date. /s/ Jason Minio, Attorney-in-Fact 2024-06-14